甲氨蝶呤在剖宫产瘢痕妊娠治疗中的应用

The application of methotrexate in the treatment of cesarean scar pregnancy

剖宫产瘢痕妊娠是妊娠囊着床于前次剖宫产子宫瘢痕处的异位妊娠,近年来其发病率明显上升,因其临床表现无特异性,常易出现漏诊、误诊等情况,可引起阴道出血、子宫破裂等并发症,对患者生命安全造成严重威胁。因此,需早期识别,及时干预。甲氨蝶呤是目前公认的最常用于剖宫产瘢痕妊娠的治疗药物,可通过多种方式发挥作用,保护患者生命安全,提高生活质量。

Cesarean scar pregnancy is a rare ectopic pregnancy with gestation sac implantation in the scar of the previous cesarean section. In recent years, its incidence has increased significantly. Due to its non-specific clinical manifestations, it is prone to missed diagnosis and misdiagnosis, which can cause vaginal bleeding, uterine rupture and other complications, posing a serious threat to the life safety of patients. Therefore, early identification and timely intervention are needed. Methotrexate is currently recognized as the most commonly used drug for the treatment of cesarean scar pregnancy. It can play its role in a variety of ways to protect patients′ life safety and improve their quality of life.